Andrew J. Mills - 17 Dec 2025 Form 3 Insider Report for Medline Inc. (MDLN)

Reporting relationship: Director
Issuer ticker: MDLN
Reported as of: 17 Dec 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 17 Dec 2025, 19:10:04 UTC
Prior SEC filing: 22 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Fritz, Attorney-in-Fact

Key filing fact

Andrew J. Mills filed Form 3 for Medline Inc. (MDLN) on 17 Dec 2025.

Key facts

This page summarizes Andrew J. Mills's Form 3 filing for Medline Inc. (MDLN).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Dec 2025, 19:10.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001460212 Primary reporting owner

Mills Andrew J.

Relationship: Director
Address: C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature: /s/ Nicole Fritz, Attorney-in-Fact
Signature date: 17 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN holding

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 30,655
Date: 17 Dec 2025
Ownership: See Footnote
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDLN holding Derivative

Common Units of Medline Holdings, LP

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 17 Dec 2025
Ownership: See Footnote
Underlying class: Class A Common Stock
Underlying amount: 30,655
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each common unit of Medline Holdings, LP ("Common Units") held. Upon an exchange of Common Units for shares of the Issuer's Class A common stock ("Class A Common Stock"), an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.

Footnote F2

These securities are held by a trust for the benefit of the Reporting Person and members of his immediate family, and of which the Reporting Person has the power to replace the trustee. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Footnote F3

Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.

SEC remarks

Exhibit 24 - Power of Attorney.